JPS52105186A - Piperazine derivative and its preparation and medicine containing same - Google Patents

Piperazine derivative and its preparation and medicine containing same

Info

Publication number
JPS52105186A
JPS52105186A JP1235677A JP1235677A JPS52105186A JP S52105186 A JPS52105186 A JP S52105186A JP 1235677 A JP1235677 A JP 1235677A JP 1235677 A JP1235677 A JP 1235677A JP S52105186 A JPS52105186 A JP S52105186A
Authority
JP
Japan
Prior art keywords
preparation
containing same
medicine containing
piperazine derivative
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1235677A
Other languages
English (en)
Inventor
Chirusu Rihiaruto
Rashiyaku Manfureeto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of JPS52105186A publication Critical patent/JPS52105186A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
JP1235677A 1976-02-07 1977-02-07 Piperazine derivative and its preparation and medicine containing same Pending JPS52105186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
JPS52105186A true JPS52105186A (en) 1977-09-03

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1235677A Pending JPS52105186A (en) 1976-02-07 1977-02-07 Piperazine derivative and its preparation and medicine containing same

Country Status (25)

Country Link
US (1) US4079137A (ja)
JP (1) JPS52105186A (ja)
AT (1) AT355578B (ja)
AU (1) AU504526B2 (ja)
BE (1) BE850492A (ja)
CA (1) CA1094560A (ja)
CH (1) CH631448A5 (ja)
CS (1) CS201544B2 (ja)
DD (1) DD128133A5 (ja)
DE (1) DE2604845A1 (ja)
DK (1) DK138891C (ja)
ES (1) ES455691A1 (ja)
FI (1) FI63226C (ja)
FR (1) FR2340311A1 (ja)
GB (1) GB1550545A (ja)
HU (1) HU173483B (ja)
IE (1) IE44339B1 (ja)
IL (1) IL51316A (ja)
LU (1) LU76706A1 (ja)
NL (1) NL7700841A (ja)
NO (1) NO142625C (ja)
PL (1) PL105526B1 (ja)
PT (1) PT66154B (ja)
SE (1) SE7701187L (ja)
ZA (1) ZA77248B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
AU2005314271B2 (en) 2004-12-06 2011-06-16 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
CA2708229A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
EP2230908A1 (en) * 2007-12-14 2010-09-29 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
CN113855806A (zh) 2014-10-21 2021-12-31 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate

Also Published As

Publication number Publication date
CH631448A5 (de) 1982-08-13
DK138891C (da) 1979-04-23
DK138891B (da) 1978-11-13
IL51316A0 (en) 1977-03-31
DK49077A (da) 1977-08-08
DE2604845A1 (de) 1977-08-18
PL105526B1 (pl) 1979-10-31
BE850492A (fr) 1977-07-18
AU2195277A (en) 1978-08-10
IE44339B1 (en) 1981-10-21
PT66154B (fr) 1978-07-07
SE7701187L (sv) 1977-08-08
FI770398A (ja) 1977-08-08
ES455691A1 (es) 1978-01-01
NO142625B (no) 1980-06-09
LU76706A1 (ja) 1977-06-28
IE44339L (en) 1977-08-07
FR2340311B1 (ja) 1980-02-08
AU504526B2 (en) 1979-10-18
CS201544B2 (en) 1980-11-28
GB1550545A (en) 1979-08-15
HU173483B (hu) 1979-05-28
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
CA1094560A (en) 1981-01-27
NO770374L (no) 1977-08-09
ZA77248B (en) 1977-11-30
FR2340311A1 (fr) 1977-09-02
DD128133A5 (de) 1977-11-02
PT66154A (fr) 1977-03-01
ATA68177A (de) 1979-08-15
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
NL7700841A (nl) 1977-08-09
NO142625C (no) 1980-09-17
FI63226C (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
JPS52105162A (en) Phthleic derivatives and preparation thereof
JPS5318557A (en) Novel aminoalkylfuran derivatives* their preparation and medical composition containing same
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL51660A (en) Hentriakontapetides being -endorphins their preparation and pharmaceutical compostions containing them
NZ185981A (en) Piperazine derivatives and pharmaceutical compositions
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
HK60184A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
JPS5379841A (en) Aminoosugar derivative * its preparation and use
JPS5297921A (en) Aralkylaniline derivative* preparation thereof and medical composition containing same
JPS5340765A (en) Novel indole derivative* its preparation and medicine containing same
JPS52142060A (en) Prostaglandin derivative its preparation and medicine containing same
JPS53124238A (en) New prostan derivative * preparation thereof and medicine containing same
JPS52105186A (en) Piperazine derivative and its preparation and medicine containing same
JPS5315367A (en) 22benzilpyrrolidine* preparation thereof and medicine containing same
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
JPS5392784A (en) 1*44dihydropyridine derivative and vasolidator drugs containing same
JPS5412398A (en) Novel bispidine derivative*its preparation and drugs containing same
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
IL53552A0 (en) New piperazine derivatives their preparation and pharmaceutical compositions containing them
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
NZ186158A (en) Disubstituted piperazine derivatives and pharmaceutical compositions
IL53009A0 (en) New imidazoisoquinoline derivatives their preparation and pharmaceutical compositions containing them